University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, 53792-4108, United States
NCT Number: NCT04895085
The purpose of this research study is to learn about the factors parents consider when deciding whether their child will go to school in-person or attend from home. Investigators are also interested in learning whether access to in-home COVID testing is of value to parents and also whether it affects decision-making about returning to school.
This study is being done at UW-Madison in partnership between the Department of Pediatrics and the Department of Industrial and Systems Engineering. A total of 50 caregivers (plus their children with medical complexity) will participate in this study. Additionally, 20 caregivers involved in the study may also be invited to participate in a one-hour, virtual visit in which the caregiver demonstrates and discusses how they perform in-home COVID testing with their child.
The results of the study may help researchers advance their understanding of in-home testing strategies for children with medical complexity.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Madison, Wisconsin, 53792-4108, United States
During the first three months of the study, caregivers will be asked to perform the BinaxNOW Rapid Antigen test on their child twice-weekly. After the first three months of the study, the testing schedule will depend on the statewide (WI) community spread rate. If the rate of spread is above the threshold for higher risk of transmission in schools (defined by the CDC as ≥ 25 new cases per 100,000 population in past 7 days) caregivers will be asked to continue twice-weekly surveillance. If it is below the threshold, caregivers will be offered the option to continue twice-weekly testing or switch to symptomatic-only testing. The study staff will notify caregivers of changes in testing frequency during their weekly communication. Caregivers will be asked to document their testing activities, results, and any possible COVID-19 symptoms on a Parent Testing Log.
If testing produces a negative result, the caregiver will be instructed to document the test result on their testing log. While false negative tests are possible with asymptomatic individuals, there will be no change in standard mitigation measures based on the test results (mandatory masks in school, social distancing, hand hygiene, etc.).
If testing produces a positive result from an asymptomatic individual, the caregiver will be instructed to contact the study team immediately and then obtain a PCR (polymerase chain reaction) test within 48 hours. The study staff will assist the caregiver in making arrangements for this test. In the case of positive tests, children will be restricted from school activities per public health guidelines until the results of the PCR testing are known. If the PCR test returns as a negative result and the child is attending school in-person, they will be allowed to return to school the next day (or if symptomatic, once symptoms resolve). If the PCR returns as positive, the caregiver will be instructed to keep the child at home per public health guidelines. To support families and ensure these steps occur, the study staff will call families daily following positive tests.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
In order to be eligible to participate in this study, the caregiver/child must meet the following criteria:
Exclusion criteria
BinaxNOW Rapid Antigen System (Abbott) is a point-of-care, lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs. Internal controls are built into the testing system and results are available in 15 minutes.
The use of the BinaxNOW system is authorized under the Food and Drug Administration's Emergency Use Authorization. The test is allowed for over-the-counter, non-prescription use with or without symptoms. The test may be used with children two years and older with the help of sample collection by an adult, and the test may be self-administered by anyone aged 15 years or more.
Time frame: Study duration (up to 21 months)
Feasibility of home based COVID-19 testing will be evaluated by protocol uptake. Data will be retrieved from the study log.
Time frame: Every week up to 21 months
Feasibility of home based COVID-19 testing will be evaluated by the mean number of weekly in home COVID-19 tests run by parents/caregivers. Data will be collected by survey.
Time frame: Study duration (up to 21 months)
Data will be collected by survey.
Time frame: Study duration (up to 21 months)
Data will be collected from parents via survey.
Time frame: Study duration (up to 21 months)
Data will be collected from parents via survey.
Time frame: Study duration (up to 21 months)
Data will be collected from parents via survey.
Time frame: At month 3
Data will be collected from parents via survey.
Time frame: baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
"How many of the people who interact with your child at school have been fully vaccinated?" Response options: "None", "A few", "Some" "Most", "All", "Don't Know" Dichotomized into: ("Most" or "All") vs. ("None", "A few", "Some", "Don't Know)
Time frame: baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
The following question from the Participant's perceived susceptibility survey will be answered dichotomously and presented qualitatively:
Time frame: baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Following questions from the Participant's perceived susceptibility survey will be answered dichotomously (agree or disagree) and presented qualitatively.
Time frame: 15 month, 18 month, 21 month, 24 month
Parent survey perceived severity construct variables will include:
Time frame: 15 month, 18 month, 21 month, 24 month
Parent survey perceived severity construct variables will be:
Time frame: 15 month, 18 month, 21 month, 24 month
Parent survey perceived severity construct variables will be:
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month
Participants will answer the following survey question in quite a bit / a great deal vs not:
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, impact on family. Survey will be analyzed qualitatively.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, and impact on family. Survey will be analyzed qualitatively.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, impact on family. Survey will be analyzed qualitatively.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, impact on family. Survey will be analyzed qualitatively.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, impact on family. Survey will be analyzed qualitatively.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Parent survey perceived benefits construct survey will be having 6 questions ranging from benefits to child's overall health, therapy needs, impact on family. Survey will be analyzed qualitatively.
Time frame: baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely vs not.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely vs not.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely [comfortable] vs not.
Time frame: Baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Survey will have following questions which will be answered dichotomously very/extremely vs not.
Time frame: baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Participants will answer the following survey question in Yes/No:
Time frame: baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Participant will be asked the attendance question in survey. It will be answered in Yes/No
Time frame: baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month, 24 month
Participant will be asked the attendance question in survey. It will be answered in Yes/No.
Survey branching logic asked this question only to participants whose child was not currently attending school in person, either full-time or as part of a hybrid or part-time schedule. The number analyzed represents the number of participants that answered this question.
University of Wisconsin, Madison
Other
ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort SARS-CoV-2 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04899245
COVID-19, Children With Medical Complexity (CMC)
Madison, Wisconsin, United States
View Trial DetailsNCT04794829
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial DetailsNCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT07722000
COVID-19, Chronic Disease
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial Details